| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88fd9074e7f5629511f3a410b1316b5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48fb25191ad3bff839a3d95b82f810f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f983d06937499833117f0449f3f59d7c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-012 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5141c30b4e49c1f8a7bb05fbc2890a41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da6d6999bf53e4bc59293029bd99f186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9ccb38598200c8868a9afffe7c98bbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a8c2bed279b747d16b72dc47c0b3e6 |
| publicationDate |
2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2879698-A2 |
| titleOfInvention |
Use of attenuated strains of toxoplasma for the prevention or treatment of cryptosporidiosis |
| abstract |
The present invention concerns strains of Sarcocystidae chosen from Toxoplasma spp or Neospora spp isolated from the natural environment of same and having an immunostimulating effect for the use of same in the prevention or treatment, in a mammal, of a pathology associated with an apicomplexan of the Cryptosporidium family. |
| priorityDate |
2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |